CYP1A1 and colitis: Only the mRNA expression of Cyp1a1 in liver samples of the mice pre-treated by a 2 week administration of SB prior to DSS (group 4) has shown a significant increase compared to group 5 with DSS-induced colitis (Figure 4A).